ClinConnect ClinConnect Logo
Search / Trial NCT04067830

Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Launched by ROSWELL PARK CANCER INSTITUTE · Aug 21, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how respiratory muscle training, which strengthens the muscles we use to breathe, can help prevent lung problems after surgery in patients with stage I to IIIB lung cancer. Many patients who undergo surgery for lung cancer face complications like pneumonia, difficulty breathing, or reduced ability to move around afterward. By improving their lung health before surgery through this training, researchers hope to make recovery easier and enhance the overall quality of life for these patients.

To participate, individuals must have a documented diagnosis of stage I to IIIB lung cancer and be preparing for a specific type of surgery aimed at treating their cancer. They should be able to speak, read, and understand English, and be willing to follow instructions for the study. Patients who are pregnant, have serious heart conditions, or cannot follow the study’s requirements will not be eligible. Those who take part can expect to engage in respiratory muscle training before their surgery, which may lead to better outcomes and fewer complications afterward.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Documented stage I-IIIb lung cancer or is undergoing surgery for diagnosis
  • Participant is able to speak, read, and comprehend English
  • Participant must be undergoing or is anticipated to either video-assisted thoracic surgery (VATS or robotic surgery) or laparoscopic surgery for curative intent lung resection
  • Patients with or without neoadjuvant chemoradiotherapy (CRT) prior to surgery will be included
  • Ability to follow written and verbal instructions
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
  • Exclusion Criteria:
  • Documented ischemic heart disease; congestive heart failure or; significant cardiac arrhythmias that would exclude them from having surgery
  • Overall medical frailty (clinician discretion) or ECOG \> 2
  • Pregnant or nursing female participants
  • Unwilling or unable to follow protocol requirements
  • Any condition which in the investigator's opinion deems the participant an unsuitable candidate to participate in this study

About Roswell Park Cancer Institute

Roswell Park Cancer Institute is a leading biomedical research and treatment center dedicated to advancing cancer care through innovative research, education, and patient-centered clinical services. Established in 1898, it is recognized for its pioneering contributions to cancer research and treatment, making significant strides in immunotherapy, precision medicine, and cancer prevention. With a commitment to translating scientific discoveries into effective therapies, Roswell Park conducts a wide range of clinical trials aimed at improving outcomes for cancer patients. Its multidisciplinary team of experts collaborates to provide comprehensive care while fostering an environment of discovery and hope for patients and their families.

Locations

Buffalo, New York, United States

Patients applied

0 patients applied

Trial Officials

Saikrishna S Yendamuri

Principal Investigator

Roswell Park Cancer Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials